Merck & Co Inc (NYSE:MRK)

77.11
Delayed Data
As of 4:00pm ET
 -0.31 / -0.40%
Today’s Change
52.83
Today|||52-Week Range
80.19
+37.04%
Year-to-Date
MRK Regular Dividend: MRK will begin trading ex-dividend on 12/14/18 with a $0.55 dividend payable to shareholders of record as of 12/17/18.

Today’s Trading

Previous close77.42
Today’s open77.92
Day’s range76.54 - 78.31
Volume13,232,513
Average volume (3 months)10,469,113
Market cap$194.5B
Data as of 4:00pm ET, 12/11/2018

Growth & Valuation

Earnings growth (last year)-38.03%
Earnings growth (this year)+9.06%
Earnings growth (next 5 years)+8.77%
Revenue growth (last year)+1.23%
P/E ratio62.6
Price/Sales3.87
Price/Book5.87

Competitors

 Today’s
change
Today’s
% change
NVSNovartis+0.32+0.37%
PFEPfizer-0.39-0.88%
ABBVAbbVie+0.56+0.64%
ABTAbbott Laboratories+0.92+1.30%
Data as of 4:02pm ET, 12/11/2018

Financials

Next reporting dateFebruary 1, 2019
EPS forecast (this quarter)$1.05
Annual revenue (last year)$40.0B
Annual profit (last year)$2.4B
Net profit margin5.99%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
CFO &
Executive Vice President-Global Services
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts